NCT00567099 Remediation of Schizophrenia Sensory Gating Deficit With Aripiprazole Status UNKNOWN Phase NA
NCT00566618 Dasatinib in Combination With Zoledronic Acid for the Treatment of Breast Cancer With Bone Metastasis Status COMPLETED Phase PHASE1/PHASE2
NCT00565773 Belatacept Post Depletional Repopulation to Facilitate Tolerance Status COMPLETED Phase PHASE2
NCT00564876 Phase II Study Evaluating The Safety And Response To Neoadjuvant Dasatinib In Early Stage Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00564187 Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice Status COMPLETED Phase PHASE4
NCT00562809 The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension Status COMPLETED Phase PHASE4
NCT00562250 Pharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy Subjects Status COMPLETED Phase PHASE1
NCT00561964 Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria Status COMPLETED Phase PHASE3
NCT00560352 Safety Study of Dasatinib With Bortezomib (Velcade®) and Dexamethasone for Multiple Myeloma Status TERMINATED Phase PHASE1
NCT00559247 A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects Status COMPLETED Phase PHASE1/PHASE2
NCT00558584 Multicenter Study of Immunoadsorption in Dilated Cardiomyopathy Status COMPLETED Phase NA
NCT00558506 Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis Status UNKNOWN Phase PHASE2
NCT00556140 The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression Status COMPLETED Phase PHASE3
NCT00550615 Dasatinib in Relapsed or Refractory Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE1/PHASE2
NCT00550017 A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) Status TERMINATED Phase PHASE1/PHASE2